NIGERIA PHARMA

INDUSTRY
Key drivers and restraints

Pharmaceutical Industry in Nigeria Key Drivers and Restraints

Drivers
Continuous
burden of
infectious
diseases

Largest
reservoir of
malaria, TB and
AIDS
Recent
outbreak of
Ebola virus
Increased
public health
coverage (90%)
Expanded
program on
immunization
(EPI)

Restraints
Increasing
incidence
of NCDs

Increasing
adoption of
western
lifestyle
NCDs to
constitute
21% by 2030
Steep rise in
chronic
drugs to
essential
medicines
ratio

Increased
healthcare
spending

Pharmaceutical
spending in
Africa to reach
$35 billion by
2018
Implementation
of NHIS to
improve access
and availability
of drugs
FDI in Africa
expected to
double by 2016

Weak
distribution
systems

Inadequate
number of
pharmacies
and private
clinics
Counterfeit
drugs and
illegitimate
drug
trading

Weak
regulatory
policies

Poor
diagnosis
and patient
awareness

Drug registration
Poor
process time
knowledge of
consuming and
diagnostic
open to corruption
procedures
Absence of
Patients
structured pricing
skeptical
system poses
about use of
challenge to public
modern
sector
medicines
Private sector
Lack of
challenged by high
trained
out-of pocket
doctors and
spending
Source: nurses
Frost & Sullivan

Ref: presentation in cphi france 2014

by Aiswariya Chidambaram
(Senior Research Analyst - Life Sciences)
Frost Sullivan